###begin article-title 0
Lack of Association between Hepatitis B Virus Infection and Polymorphism of Mannose-Binding Lectin Gene in Korean Population
###end article-title 0
###begin p 1
###xml 186 189 186 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBL</italic>
###xml 833 834 833 834 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 997 1000 997 1000 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBL</italic>
###xml 1073 1074 1073 1074 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 137 154 <span type="species:ncbi:10407">hepatitis B virus</span>
###xml 275 283 <span type="species:ncbi:9606">patients</span>
###xml 289 306 <span type="species:ncbi:10407">hepatitis B virus</span>
###xml 862 879 <span type="species:ncbi:10407">hepatitis B virus</span>
###xml 1158 1175 <span type="species:ncbi:10407">hepatitis B virus</span>
###xml 1224 1241 <span type="species:ncbi:10407">hepatitis B virus</span>
Mannose-binding lectin (MBL) plays an important role in immune defense. This study was undertaken to investigate the association between hepatitis B virus infection and polymorphisms of MBL gene. We assessed the single nucleotide polymorphism at codon 54 in exon 1 of MBL in patients with hepatitis B virus infection and HBsAg negative controls in Korean population. A total of 498 enrolled subjects was classified into four groups. Group 1; Clearance, Group 2; Inactive healthy carrier, Group 3; Chronic hepatitis, Group 4; Liver cirrhosis. MBL gene polymorphisms at codon 54 led to three genotypes (G/G, G/A, A/A). When we divided subjects into clearance group (group 1) and persistence group (group 2-4), G/G genotype and A-allele carrier were observed in 55.6% and 44.4% in clearance group, 64.8% and 35.2% in persistence group (p=0.081), respectively. When hepatitis B virus persistent cases were divided into inactive healthy carrier (group 2) and disease progression group (group 3 and 4), MBL gene polymorphisms at codon 54 were not related to disease progression (p=0.166). MBL gene polymorphism at codon 54 was not associated with the clearance of hepatitis B virus infection nor progression of disease in chronic hepatitis B virus infection.
###end p 1
###begin title 2
INTRODUCTION
###end title 2
###begin p 3
###xml 205 206 205 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 667 668 667 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 15 32 <span type="species:ncbi:10407">hepatitis B virus</span>
###xml 34 37 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 266 269 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 452 455 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 501 518 <span type="species:ncbi:10407">hepatitis B virus</span>
###xml 725 728 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
Infection with hepatitis B virus (HBV) may result in various conditions ranging from inactive healthy carrier to chronic hepatitis, liver cirrhosis, and sometimes may progress to hepatocellular carcinoma (1). The reasons for this variation in the natural history of HBV infection are unknown but are probably related to host immune factors. Chronic infection develops in approximately 5% of immunocompetent adults, but up to 90% of newborns may become HBV carriers if the mothers are seropositive for hepatitis B virus e antigen (HBeAg). In hepatitis endemic area such as China and Korea, vertical transmission is the most important cause of hepatitis B persistence (2), but this cannot completely explain the persistence of HBV infection.
###end p 3
###begin p 4
###xml 115 116 115 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 211 212 211 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 327 328 327 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 249 252 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 368 373 <span type="species:ncbi:9606">human</span>
###xml 418 421 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
Mannose-binding lectin (MBL) is an acute-phase protein involved in activation of the classical complement pathway (3). MBL acts as a direct opsonin by binding to collectin receptors through its collagen domain (4). The middle surface protein of the HBV envelope contains a mannose-rich oligosaccharide to which MBL could bind (5). MBL is an important component of the human innate immune system and may play a role in HBV infection.
###end p 4
###begin p 5
###xml 242 243 236 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 268 271 262 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBL</italic>
###xml 413 416 407 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBL</italic>
###xml 459 460 453 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 518 521 512 515 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBL</italic>
###xml 586 587 580 581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 588 590 582 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 741 744 735 738 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBL</italic>
###xml 544 547 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 551 568 <span type="species:ncbi:11103">hepatitis C virus</span>
###xml 570 573 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 640 643 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 832 835 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
To date three single nucleotide polymorphisms (SNPs) have been well characterized in exon 1 at codons 52 (CGT-->TGT), codon 54 (GGC-->GAC) and codon 57 (GGA-->GAA), and these differ considerably in their frequencies in different populations (6). It is well known that MBL gene mutation leads to low serum MBL level, which in turn makes affected individuals more prone to infection. SNPs in codon 54 and 57 of the MBL gene are related to low serum MBL levels (7). Several investigators reported the association between MBL gene polymorphism and HBV or hepatitis C virus (HCV) infection (8-11). However, reports concerning the role of MBL in HBV infections are conflicting. Furthermore, there are no data available regarding the prevalence of MBL gene SNPs in the Korean population and the role of these SNPs in the natural course of HBV infection.
###end p 5
###begin p 6
###xml 97 100 97 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBL</italic>
###xml 244 247 244 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBL</italic>
###xml 116 124 <span type="species:ncbi:9606">patients</span>
###xml 281 284 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
Therefore, we have investigated the genotype frequencies at codon 54 in the coding region of the MBL gene in Korean patients with chronic hepatitis B, liver cirrhosis, and who recovered infection, and have tried to find any association between MBL gene SNPs and natural history of HBV infection.
###end p 6
###begin title 7
MATERIALS AND METHODS
###end title 7
###begin title 8
Study subjects
###end title 8
###begin p 9
###xml 100 107 <span type="species:ncbi:9606">patient</span>
###xml 266 269 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 290 293 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 374 377 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 875 878 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
Between March 2002 and September 2002, a total of 498 subjects was enrolled prospectively, from out-patient clinic of the Gastroenterology Department of Ajou University Hospital, Suwon, Korea. They were classified into four groups according to the various status of HBV infection. Group 1; HBV Clearance group [n=126, HBsAg (-), AntiHBc (+), AntiHBs (+), who recovered from HBV infection], Group 2; Inactive healthy carrier group [n=58, HBsAg (+) and HBeAg (-), sustained normal transaminase level], Group 3; Chronic hepatitis [n=239, HBsAg (+), elevated transaminase (>/=2 times the upper limit of normal at least one time during the follow-up period], Group 4; Liver cirrhosis [n=75, typical morphologic findings on computed tomography/ultrasound and corresponding laboratory features or evidence of portal hypertension]. Among them, group 2, 3 and 4 were classified into "HBV persistence group".
###end p 9
###begin p 10
###xml 36 39 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 251 259 <span type="species:ncbi:9606">patients</span>
###xml 340 348 <span type="species:ncbi:9606">patients</span>
###xml 431 439 <span type="species:ncbi:9606">patients</span>
The diagnostic criteria for chronic HBV infection were seropositivity for HBsAg for more than 6 months, seronegativity for anti-HBs and presence of anti-HBc, and were followed up for disease progression. Inactive healthy carrier and chronic hepatitis patients had no evidence of portal hypertension and/or liver cirrhosis. None of enrolled patients had hepatocellular carcinoma. The chronic hepatitis (group 3) and liver cirrhosis patients (group 4) were considered to have chronic progressive liver disease, classified as "progressive group" when compared with inactive healthy carriers (group 2).
###end p 10
###begin p 11
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
###xml 97 105 <span type="species:ncbi:9606">patients</span>
###xml 189 200 <span type="species:ncbi:11103">hepatitis C</span>
###xml 415 420 <span type="species:ncbi:9606">Human</span>
Patients who were positive for anti-HBs and negative for anti-HBc IgG (vaccinated subjects), and patients with other types of chronic liver disease such as alcoholic liver disease, chronic hepatitis C, steatohepatitis, Wilson's disease, were excluded from this study. All the subjects were Korean, a single ethnic population. Informed consents were obtained from each subject, and the Institutional Review Board of Human Research of Ajou University Hospital approved the study protocol.
###end p 11
###begin title 12
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBL</italic>
MBL Genotyping
###end title 12
###begin p 13
###xml 31 34 31 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBL</italic>
###xml 223 226 223 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBL</italic>
###xml 299 302 299 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBL</italic>
###xml 502 505 498 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBL</italic>
###xml 513 521 <span type="species:ncbi:9606">patients</span>
###xml 527 530 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 596 599 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
Before the analysis, we tested MBL gene polymorphism at codon 52, 54 and 57 in 100 healthy Korean populations. In this pilot assay, we could not find any polymorphism at codon 52 and codon 57 in Korean population. The only MBL gene SNP found in our Korean population was that at codon 54 of exon 1. MBL gene polymorphism was identified only at codon 54 (Glycine-->Aspartate, GGC-->GAC), leading to three genotype (G/G, G/A, A/A genotype). Therefore, we assessed the genetic polymorphism at codon 54 of MBL in 372 patients with HBV infection, and in 126 HBsAg negative controls who had eliminated HBV.
###end p 13
###begin p 14
###xml 174 177 170 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBL</italic>
Genomic DNA was extracted from 300 microL whole blood using a DNA Purification kit (GENTRA, Minneapolis, MN, U.S.A.) according to the manufacturer's instructions. The SNP of MBL gene codon 54 was detected by polymerase chain reaction (PCR) amplification. The parameters for thermocycling were as follows: An initial activation step of 95℃ for 10 min preceded the cycling program; followed by 35 cycles of denaturation at 95℃; annealing at 72℃ for 1 min; and final extension at 72℃ for 7 min. Each PCR products were purified by a Qiagen PCR purification kit, and the polymorphisms were detected by single base primer extension assay (SNP ITtrade mark). Briefly, the assay is to anneal a detection primer to the nucleic acid sequence immediately 3' of the nucleotide position to be analyzed and to extend this primer with a single labeled nucleoside triphosphate that is complementary to the nucleotide to be detected using a DNA polymerase.
###end p 14
###begin title 15
Statistical analysis
###end title 15
###begin p 16
###xml 28 29 26 27 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 89 92 87 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBL</italic>
###xml 296 297 294 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 326 327 324 325 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
For univariate analysis, chi2 test was used for Hardy-Weinberg equilibrium of alleles at MBL gene loci and independent sample t test for normally distributed continuous variables. The analysis was carried out using the statistical computer software SPSS11.0/Windows (SPSS Inc., Chicago, IL). All p values were two-tailed, and p value <0.05 was considered to indicate statistical significance throughout the study.
###end p 16
###begin title 17
RESULTS
###end title 17
###begin p 18
###xml 145 152 145 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 49 52 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 389 392 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 444 447 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 684 687 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 740 743 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
Demographic characteristics of the subjects with HBV clearance vs. persistence groups and inactive carrier vs. progression groups, were shown in Table 1. Differences between clearance and persistence groups in aspartate transaminase/alanine transaminase (AST/ALT), platelet, alpha-fetoprotein (AFP) were observed. The serum levels of AST, ALT, AFP at baseline were significantly higher in HBV persistence group. The platelet count was lower in HBV persistence group. Age was younger in persistence group, but no significant differences in the distributions of their gender were detected between clearance group and persistence group. Concerning the comparison of inactive carrier and HBV progression group, male sex was the risk factor for HBV progression, but there was no difference in age distribution.
###end p 18
###begin p 19
###xml 36 39 36 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBL</italic>
###xml 117 120 117 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBL</italic>
###xml 169 176 169 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">Table 2</xref>
###xml 213 216 213 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBL</italic>
###xml 142 150 <span type="species:ncbi:9606">patients</span>
###xml 276 284 <span type="species:ncbi:9606">patients</span>
Genotype data were complete for the MBL gene markers in all of the subjects. The frequencies of the genotypes of the MBL codon 54 in enrolled patients are summarized in Table 2. Allelic frequencies in codon 54 of MBL gene are as follows. In group 1, G/G genotype was 55.6% of patients, G/A genotype was 41.3%, A/A genotype was 3.2%. In group 2, G/G, G/A, A/A genotype frequencies were 67.2%, 29.3% and 3.4%, respectively. In group 3, G/G, G/A, A/A genotype frequencies were 63.6%, 32.6% and 3.8%, respectively. In group 4, G/G, G/A, A/A genotype frequencies were 66.7%, 32.0% and 1.3%.
###end p 19
###begin title 20
###xml 21 24 21 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBL</italic>
###xml 51 54 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
Associations between MBL gene SNPs at codon 54 and HBV clearance
###end title 20
###begin p 21
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBL</italic>
###xml 167 174 167 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T3">Table 3</xref>
###xml 192 195 192 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBL</italic>
###xml 640 641 640 641 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 43 51 <span type="species:ncbi:9606">patients</span>
###xml 65 68 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 138 141 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 467 470 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
MBL gene SNPs at codon 54 were analyzed in patients with chronic HBV infection ("persistence") and healthy individuals who recovered from HBV infection ("clearance") (Table 3). Since specific MBL genotype has been linked to MBL protein production and phenotype, we repeated the analysis of data comparing G/G genotype and A-allele carrier among the different groups. The frequencies of G/G genotype and A-allele carrier (G/A, A/A) were observed in 55.6% and 44.4% in HBV clearance group, 64.8% and 35.2% in persistence group. Comparison of genotype frequencies showed no significant differences between the clearance and persistence group (p=0.081).
###end p 21
###begin title 22
###xml 21 24 21 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBL</italic>
###xml 39 42 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
Associations between MBL gene SNPs and HBV disease progression
###end title 22
###begin p 23
###xml 21 24 21 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBL</italic>
###xml 289 292 289 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBL</italic>
###xml 432 433 432 433 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 442 449 442 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T4">Table 4</xref>
###xml 80 83 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 357 360 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 408 411 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
We evaluated whether MBL gene polymorphism is related to disease progression in HBV infection by comparing the genotype frequency between inactive carriers (group 2) and progressive group (group 3 and 4). No significant differences were detected between two groups in the distributions of MBL gene genotype at codon 54 (G/G:67.2%, A allele carrier:32.8% in HBV healthy carrier, G/G:64.3%, A-carrier:35.7% in HBV progression group) (p=0.166) (Table 4).
###end p 23
###begin title 24
DISCUSSION
###end title 24
###begin p 25
###xml 140 142 140 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 15 18 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 160 163 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 213 221 <span type="species:ncbi:9606">patients</span>
###xml 529 532 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 612 615 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 721 724 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 869 872 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 897 902 <span type="species:ncbi:9606">child</span>
###xml 1003 1006 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 1219 1222 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
The persistent HBV infection is a major public health problem, particularly in the hepatitis endemic areas such as Korea, Taiwan and China (12). Elimination of HBV after infection depends on the activities of the patients' immune systems. It is well established that several host factors, including age at the time of infection, sex, immune status and possibly ethnic origin, are important in promoting development of chronic hepatitis B infection. These factors may have confounding impacts on this study. The family history of HBV infection was not completely evaluated and it was hard to presume the onset of HBV infection. Therefore, we were not able to compare the effect of the polymorphism on the risk for chronic HBV infection to that of the age at which the subject is infected. However, considering the finding that perinatal or early childhood infections of HBV, particularly mother-to-child transmission of the virus, is the most common source of chronic infection in the endemic area, most HBV persistent subjects in this study are considered to be infected in this manner. Moreover, our study included single ethnic population. Therefore, we have minimized the confounding factors affecting the course of HBV infection.
###end p 25
###begin p 26
###xml 254 255 254 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 257 259 257 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 261 263 261 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 389 391 389 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 562 564 562 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 874 876 858 860 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 239 242 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 374 377 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 461 464 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 838 841 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
The host genetic factors involving genetic polymorphisms are reported to play a key role in influencing clinical outcomes of infectious disease. A number of studies have identified polymorphisms that influence susceptibility to persistent HBV infection (9, 13, 14). Previous reports suggest that DRB1*1301 and *1302 allele are both protective against development of chronic HBV infection (15). A protective effect of DRB1*1301, *1302 against the development of HBV persistence has been suggested in a study on an ethnically heterogeneous group of west Africans (13). Cytokine polymorphisms such as tumor necrosis factor-alpha (TNF-alpha) or interleukin-10 (IL-10) were investigated. Recently, Kim et al. reported that TNF-alpha promoter allele associated with higher-plasma TNF-alpha levels was strongly associated with the resolution of HBV infection in Korean population (14).
###end p 26
###begin p 27
###xml 11 13 11 13 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 83 84 83 84 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 222 223 222 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 257 260 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
MBL is a Ca2+ dependent serum lectin specific for mannose and N-acetylglucosamine (4). MBL has been known to have an important role in innate immunity and has been shown to have complement dependent bactericidal activity (3). The middle envelope protein of HBV has an asparagine residue at position 4. This residue is glycosylated with an oligosaccharide, which is, in part, mannose-terminated. Therefore, opsonization of viral particle by normal serum MBL is possible.
###end p 27
###begin p 28
###xml 85 88 85 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBL</italic>
###xml 95 96 95 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 172 175 172 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBL</italic>
###xml 273 276 273 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBL</italic>
###xml 686 687 686 687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 744 747 744 747 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBL</italic>
###xml 1043 1045 1043 1045 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 154 157 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 412 420 <span type="species:ncbi:9606">patients</span>
###xml 561 569 <span type="species:ncbi:9606">patients</span>
###xml 890 893 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 1093 1096 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
MBL serum levels are profoundly reduced by polymorphisms in the coding region of the MBL gene (7). Concerning the relationship between natural history of HBV infection and MBL gene SNPs, many reports showed conflicting results. Yuen et al. showed that codon 54 mutation of MBL gene was associated with progression of disease in chronic hepatitis B infection in Chinese population. According to their reports, in patients with decompensated cirrhosis, the codon 54 mutation rate was greatly increased. And they found that spontaneous bacterial peritonitis (SBP) patients had marked increase in codon 54 mutation rate and decrease in serum MBL level when compared with those without SBP (8). In Caucasian population, mutant allele at codon 52 of MBL gene was reported to be associated with chronic hepatitis B infection. But, they failed to reveal the association between SNP at codon 52 and HBV persistence in Asian population. Furthermore, there was no association of the codon 54 or codon 57 mutant alleles with acute or chronic hepatitis B (11). Therefore, the role of MBL in the outcome of HBV infection still remains unclear.
###end p 28
###begin p 29
###xml 248 250 248 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 102 105 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 233 236 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 326 329 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 504 507 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
Our study demonstrated that the SNP at the second position of codon 54 of MBL was not associated with HBV persistence. This result was consistent with the previous report, which showed that this polymorphism have no association with HBV clearance (16). We included more than 100 individuals who were completely recovered from HBV infection as control. Furthermore, we believe that the controls in our study were more relevant to evaluate the role of host genetic factor in determining viral clearance of HBV.
###end p 29
###begin p 30
###xml 27 30 27 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBL</italic>
###xml 197 198 197 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 280 283 280 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBL</italic>
###xml 182 185 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 607 615 <span type="species:ncbi:9606">patients</span>
###xml 776 784 <span type="species:ncbi:9606">patients</span>
###xml 798 801 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 901 904 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
We found no association of MBL gene SNP at codon 54 with disease progression. There are a few studies suggesting the relationship of the polymorphism with the disease progression of HBV infection (8). In the present study, the number of subjects with A/A genotypes at codon 54 of MBL gene was limited, so we had difficulty in assessing any possible association between the genotypes and clinical features. Such ethnic differences in the distribution of the polymorphisms may account for the lack of the correlation in our study, which was not in agreement with other studies. In addition, the number of the patients who undergone liver biopsy during the study period was limited in the study so that we might under- or overestimate the stage of disease progression in some of patients with chronic HBV infection. It might miss possible association between the polymorphisms and disease progression in HBV infection.
###end p 30
###begin p 31
###xml 49 52 49 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBL</italic>
###xml 435 438 435 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBL</italic>
Although several studies have suggested that the MBL gene SNP alter MBL production, it was mostly based on in vitro experiments. The results would be different according to the type of the stimuli or experimental conditions. MBL expression may also be disease stage-specific, and serum levels may not necessarily correlate with the local MBL levels in liver. Further studies are needed to evaluate the exact functional consequences of MBL polymorphisms on MBL level in both peripheral blood and liver cells at various stages of disease progression.
###end p 31
###begin p 32
###xml 69 72 69 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBL</italic>
###xml 101 104 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 241 244 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
In conclusion, this study suggested that polymorphism at codon 54 of MBL gene is not associated with HBV clearance nor disease progression in Korean population. Further studies should continue to address the effect of these polymorphisms on HBV infection.
###end p 32
###begin p 33
###xml 72 121 72 121 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ministry of Health and Welfare, Republic of Korea</funding-source>
###xml 123 146 123 146 <award-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">01-PJ10-PG6-01GN14-0007</award-id>
This study was supported by a grant from the Korean Health R&D project, Ministry of Health and Welfare, Republic of Korea (01-PJ10-PG6-01GN14-0007).
###end p 33
###begin article-title 34
The treatment of chronic viral hepatitis
###end article-title 34
###begin article-title 35
###xml 84 92 <span type="species:ncbi:9606">children</span>
Placebo-controlled trial of recombinant alpha 2-interferon in Chinese HBsAg-carrier children
###end article-title 35
###begin article-title 36
Activation of the classical complement pathway by mannose-binding protein in association with a novel C1s-like serine protease
###end article-title 36
###begin article-title 37
Serum lectin with known structure activates complement through the classical pathway
###end article-title 37
###begin article-title 38
###xml 45 62 <span type="species:ncbi:10407">hepatitis B virus</span>
Studies on the attachment and penetration of hepatitis B virus
###end article-title 38
###begin article-title 39
High frequencies in African and non-African populations of independent mutations in the mannose binding protein gene
###end article-title 39
###begin article-title 40
Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein
###end article-title 40
###begin article-title 41
Mannose binding lectin gene mutations are associated with progression of liver disease in chronic hepatitis B infection
###end article-title 41
###begin article-title 42
###xml 46 63 <span type="species:ncbi:10407">hepatitis B virus</span>
###xml 88 96 <span type="species:ncbi:9606">patients</span>
Mannose-binding lectin gene polymorphisms and hepatitis B virus infection in Vietnamese patients
###end article-title 42
###begin article-title 43
###xml 0 17 <span type="species:ncbi:11103">Hepatitis C virus</span>
Hepatitis C virus infection and mutations of mannose-binding lectin gene MBL
###end article-title 43
###begin article-title 44
Mutation of gene of mannose-binding protein associated with chronic hepatitis B viral infection
###end article-title 44
###begin article-title 45
Vertical transmission of hepatitis B antigen in Taiwan
###end article-title 45
###begin article-title 46
###xml 60 77 <span type="species:ncbi:10407">hepatitis B virus</span>
Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia
###end article-title 46
###begin article-title 47
###xml 70 87 <span type="species:ncbi:10407">hepatitis B virus</span>
Association of TNF-alpha promoter polymorphisms with the clearance of hepatitis B virus infection
###end article-title 47
###begin article-title 48
HLA-DRB1*1301 and *1302 protect against chronic hepatitis B
###end article-title 48
###begin article-title 49
###xml 84 101 <span type="species:ncbi:10407">hepatitis B virus</span>
###xml 122 130 <span type="species:ncbi:9606">patients</span>
No association between mannose-binding lectin alleles and susceptibility to chronic hepatitis B virus infection in German patients
###end article-title 49
###begin p 50
###xml 31 39 <span type="species:ncbi:9606">patients</span>
Demographic characteristics of patients
###end p 50
###begin p 51
NS, not significant; AFP, alpha-fetoprotein; AST, aspartate transaminase; ALT, alanine transaminase
###end p 51
###begin p 52
###xml 24 27 24 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBL</italic>
Genotype frequencies in MBL gene codon 54 in enrolled subjects
###end p 52
###begin p 53
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
*, chronic progressive liver disease: chronic hepatitis and liver cirrhosis.
###end p 53
###begin p 54
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBL</italic>
###xml 26 29 26 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HBV</italic>
###xml 26 29 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
MBL gene polymorphism and HBV persistence
###end p 54
###begin p 55
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBL</italic>
###xml 26 29 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
MBL gene polymorphism and HBV disease progression
###end p 55

